Keywords: Cytopathology, Nucleic acid test, Artificial intelligence
Shenzhen YOUYI Bioscience Ltd. (YOUYIBIO) is based on clinical values and committed to the field of molecular diagnosis, cytopathology, and artificial intelligence. Our main focus is the research and development, manufacture, and sales of molecular diagnostic and cytopathologic products with excellent performance, reliable quality, and automatic operation.YOUYIBIO devotes itself to providing complete solutions for disease screening and auxiliary diagnosis，and some typical examples are:
1. A complete solution for cervical cancer screening
A complete solution for cervical cancer screening with ready-to-use reagents and automatic equipment, including p16/Ki-67 dual staining of cervical exfoliated cells，and HPV test kits (including HPV Full genotyping kits and High risk HPV test). Meanwhile, we are developing AI software for the cytomorphologic interpretation of cervical exfoliated cells and p16/Ki-67 dual staining, which will minimize
the workload of pathologists in the near future.
2. Systematic solution for screening of global thalassemia
Solution for screening of global thalassemia: the most stable and reliable gene detection technique is adopted to identify all the common and meaningful genetic defects of α and β thalassemia globally.
3. Other nucleic acid test
Several nucleic acid test kits for genetic diseases and infection pathogens, with PCR based technology platform are ready now; and Point-of-Care Testing (POCT) utilizing electrochemistry and microfluidic technologies will be developed in the near future.
4. A complete solution for the identification and separation of liquid biopsy
We own all the core patents of the completesolution for peripheral blood cells morphology analysis with AI and microfluidic technology. Currently we are pushing to launch the first-generation prototype as soon as possible.
Our other detection systems also aim at complete solutions for more infectious diseases, hereditary diseases, and tumors, by integrating the above-mentioned technical platforms, ready-to-use
reagents, and automatic equipment.
We look forward to cooperating closely with agents.
